GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Gross Profit

CBD Life Sciences (CBD Life Sciences) Gross Profit : $0.12 Mil (TTM As of Sep. 2015)


View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Gross Profit?

CBD Life Sciences's gross profit for the three months ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's gross profit for the trailing twelve months (TTM) ended in Sep. 2015 was $0.12 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. CBD Life Sciences's gross profit for the three months ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, CBD Life Sciences's Gross Margin % for the quarter that ended in Sep. 2015 was N/A%.

CBD Life Sciences had a gross margin of N/A% for the quarter that ended in Sep. 2015 => No sustainable competitive advantage


CBD Life Sciences Gross Profit Historical Data

The historical data trend for CBD Life Sciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Gross Profit Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Gross Profit
- - 0.16 0.12

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.12 - - -

Competitive Comparison of CBD Life Sciences's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CBD Life Sciences's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Gross Profit falls into.



CBD Life Sciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

CBD Life Sciences's Gross Profit for the fiscal year that ended in Dec. 2014 is calculated as

Gross Profit (A: Dec. 2014 )=Revenue - Cost of Goods Sold
=0.123 - 0
=0.12

CBD Life Sciences's Gross Profit for the quarter that ended in Sep. 2015 is calculated as

Gross Profit (Q: Sep. 2015 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

CBD Life Sciences's Gross Margin % for the quarter that ended in Sep. 2015 is calculated as

Gross Margin % (Q: Sep. 2015 )=Gross Profit (Q: Sep. 2015 ) / Revenue (Q: Sep. 2015 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


CBD Life Sciences  (OTCPK:CBDL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

CBD Life Sciences had a gross margin of N/A% for the quarter that ended in Sep. 2015 => No sustainable competitive advantage


CBD Life Sciences Gross Profit Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


CBD Life Sciences (CBD Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.